Microba Life Sciences
Brisbane
About Microba Life Sciences
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services using technology for measuring the human gut microbiota. The company analyzes the microbiome to discover therapeutics, develop new diagnostic tools to understand disease through comprehensive measurement of the human gut microbiome. Microba Life Sciences was established in March 2017 by Philip Hugenholtz and Gene Tyson in Brisbane, Queensland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $21.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2022)
- Ticker: asx:MAP
- Website: microba.com
- Phone: 1300 974 621
Industries & Categories
Biotechnology, Genetics, Health Care, Life Science, Wellness
Social Profiles
Canonical: https://fsome.com/organization/microba-life-sciences-78929 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.